UAE Crescent Enterprises’ CE-Ventures invests in London startup Oyster Therapeutics

Résumé détaillé

UAE-based Crescent Enterprises’ CE-Ventures has invested in London-based biotech firm Oyster Therapeutics, formerly Kesmalea Therapeutics. Create a free ZAWYA account to access…

UAE-based Crescent Enterprises’ CE-Ventures has invested in London-based biotech firm Oyster Therapeutics, formerly Kesmalea Therapeutics.

Create a free ZAWYA account to access exclusive financial news, analysis, and insights.

Disclaimer: This article is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Read our full disclaimer policy here.

Début de l'article, extrait de Zawya. Pour lire la suite, ouvrez l'article chez le média.